Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Emma Rossi, MD
Indiana University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usa Mitchell Cancer Institute
Mobile, Alabama, United States
- Indiana University
Indianapolis, Indiana, United States
- St. Elizabeth Healthcare
Edgewood, Kentucky, United States
- Sunrise Hospital and Medical Center
Las Vegas, Nevada, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Tri Health Good Smaritan Hospital
Cincinnati, Ohio, United States
- University of Virginia Medical Center
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 31 Jan 2017
- Completion
- 31 Jan 2017
- Last update posted
- 24 Jul 2018
- Registered enrollment
- 430
- Registry id
- NCT01673022
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.